Skip to main content
Clinical Trials/NCT03868995
NCT03868995CompletedNot Applicable

The Efficacy of Hypertonic Dextrose Injection to Anterior Talofibular Ligament Sprain: A Randomized Controlled Trial

Taipei Medical University WanFang Hospital1 site in 1 country29 target enrollmentStarted: November 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
29
Locations
1
Primary Endpoint
Ankle pain

Study Overview

Brief Summary

Anterior talofibular ligament is the most injured ligament in ankle sprain. Investigators will include ankle sprain patients who have ankle pain or instability more than 3 months. Ultrasonography will be done for confirm ligament injury. Participants will be randomized into two groups. Participants in dextrose injection group will accept dextrose 15% injection to tendon and enthesis. In the other hand, subcutaneous sham injection to control group. Pain condition, stability test and function test, will be evaluated in 1 week, 4 weeks and 12 weeks after injection.

Detailed Description

Background: Sprains constitute most of ankle injury and 85% ankle sprain is inversion injury. The conventional treatment includes medication, physical therapy, bracing and steroid injection. Anterior talofibular ligament is the most injured ligament in ankle sprain. Although the response of acute ligament sprain is usually quickly, treatment of chronic ligament sprain is difficult. Chronic pain and ankle instability is the most common symptom in chronic ankle sprain. Dextrose prolotherapies been used for treating soft tissue injury such as osteoarthritis, tendinopathy and ligament sprain. However, there is not randomized control trial for hypertonic dextrose injection to chronic ankle sprain.

Methods: Investigators will include 40 ankle sprain patients who have ankle pain or instability sensation more than 3 months. Ultrasonography will be done for confirm ligament injury. Participants will be randomized into two groups. Dextrose injection group will accept dextrose 15% injection to tendon and enthesis. Otherwise, investigators will do subcutaneous sham injection to control group. Investigators will measure pain threshold and peak pressure by algometer, the degree of ankle instability by ultrasound, the proprioception by single leg standing, and foot and ankle questionnaire. The examination will be done before injection, immediately after injection, 1 week, 4 weeks and 12 weeks after injection.To our hypothesis, investigators suggest dextrose prolotherapy injection could decrease pain and improved proprioception.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Chronic ankle sprain more than 3months with chronic ankle pain or instability sensation
  • •Ultrasound diagnosed anterior talofibular ligament sprain

Exclusion Criteria

  • •Acute ankle sprain less than 3 months
  • •Lower limb fracture history
  • •Cognitive impairment
  • •Other neurological or muscular disorders
  • •Sever pain could not tolerate examination

Arms & Interventions

Sham injection

Sham Comparator

Dextrose water injection to subcutaneous layer at tender point

Intervention: Sham injection (Procedure)

Tendon injection

Experimental

Dextrose water injection to injured tendon

Intervention: Tendon injection (Procedure)

Outcomes

Primary Outcomes

Ankle pain

Time Frame: Change from baseline VAS at 12 week

visual analogue scale(VAS), range 0-10, the higher scale the worsen pain

Ankle pain

Time Frame: Change from baseline VAS at 1 week

visual analogue scale(VAS), range 0-10, the higher scale the worsen pain

Ankle pain

Time Frame: Change from baseline VAS at 4 week

visual analogue scale(VAS), range 0-10, the higher scale the worsen pain

Secondary Outcomes

  • Ankle proprioception(Change from baseline of difference of ankle degree at 12 weeks)
  • Ankle function(Change from baseline FADI at 12 weeks)
  • Ankle proprioception(Change from baseline of difference of ankle degree at 1 week)
  • Ankle function(Change from baseline FADI at 1 week)
  • Ankle proprioception(Change from baseline of difference of ankle degree at 4 weeks)
  • Ankle function(Change from baseline FADI at 4 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

The Efficacy of Hypertonic Dextrose... | Clinical Trial